ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds

April 24, 2009

Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says

January 31, 1997

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

HHS Proposes Stronger Health Warnings On Cigarette Packages, Ads

November 12, 2010